Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page
- Check7 days agoChange DetectedA new revision tag v3.6.4 was added to the page history, replacing the previous v3.6.3. This reflects a minor site update to the history page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, indicating a version update of the page. This update appears in the footer and does not affect the study data or visible content.SummaryDifference0.0%

- Check35 days agoChange DetectedA new revision entry (v3.6.2) was added to the study history on 2026-06-23, along with an added 'Study Status' item on 2026-05-28 and the version count updated to 62; the older revision (v3.6.0) was removed on 2026-04-09.SummaryDifference0.2%

- Check49 days agoChange DetectedRecruitment status is updated to show the study is no longer seeking participants. The history also adds a new revision tag (v3.6.0) and removes the older revision (v3.5.5).SummaryDifference0.2%

- Check57 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, indicating a new build of the ClinicalTrials.gov history page; the underlying study information remains the same.SummaryDifference0.0%

- Check78 days agoChange DetectedThe record history now includes revision v3.5.4 and removes v3.5.3, indicating an update to the page's release history. This change does not alter study content or visible information.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.